Zhongtai Securities(SH:600918) Xin Lang Cai Jing·2025-08-27 06:21Group 1 - The core viewpoint of the news is that Shenzhen Xinlitai Pharmaceutical Co., Ltd. experienced a decline in stock price, with a drop of 5.07% to 50.40 CNY per share, and a total market capitalization of 561.87 billion CNY as of August 27 [1] - The company was established on November 3, 1998, and went public on September 10, 2009. Its main business involves the research, production, and sales of pharmaceuticals and medical devices [1] - The revenue composition of the company is as follows: formulations account for 81.69%, medical devices 8.54%, raw materials 7.17%, and others 2.59% [1] Group 2 - From the perspective of fund holdings, a fund under Zhongtai Securities Asset Management has a significant position in Xinlitai, with the Zhongtai Xingrui Economic Growth Mixed A Fund (018372) reducing its holdings by 24,800 shares in the second quarter, now holding 70,300 shares, which represents 3.07% of the fund's net value [2] - The fund was established on July 18, 2023, with a latest scale of 41.0179 million CNY. Year-to-date returns are 30.46%, ranking 2003 out of 8194 in its category, while the one-year return is 40.07%, ranking 3389 out of 7963 [2] - The fund manager, Gao Lanjun, has been in the position for 6 years and 70 days, with the total asset scale of the fund at 1.08 billion CNY. The best return during his tenure is 119.52%, while the worst is 9.82% [3]